BDBM320259 N-(4-methoxycarboxylaminophenyl)-7-(5-chloro-2-(1H-tetrazol-1-yl)phenyl)-5-oxo-1,2,3,5-tetrahydroindolizine-3-carboxamide ::US10174020, Compound 7

SMILES COC(=O)Nc1ccc(NC(=O)C2CCc3cc(cc(=O)n23)-c2cc(Cl)ccc2-n2cnnn2)cc1

InChI Key InChIKey=SEFJBTVZQJNCGN-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 320259   

TargetCoagulation factor XI(Human)
Sichuan Haisco Pharmaceutical

US Patent
LigandPNGBDBM320259(N-(4-methoxycarboxylaminophenyl)-7-(5-chloro-2-(1H...)
Affinity DataKi:  344nMAssay Description:The following method was used to test the in vitro inhibitory effect of the compounds of the present invention on the activity of human blood-coagula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent